Neoleukin Therapeutics Inc (NLTX)

[Schrogtergracht]

Nasal spray... that's billion$

October 23, 2020; Science Vol. 370, Issue 6515, pp. 426-431
Note espec. end of article "Acknowledgments, Author contribution"
https://science.sciencemag.org/content/370/6515/426 (research article)
[UW, David Baker, Neoleukin, nasal spray, Moderna?]

September 9, 2020
"used computer design to originate new proteins that bind tightly to SARS-CoV-2 Spike protein and obstruct it from infecting cells. Beginning in January, more than two million candidate Spike-binding proteins were designed on the computer. Over 118,000 were then produced and tested in the lab."
https://newsroom.uw.edu/news/designed-antiviral-proteins-inhibit-sars-cov-2-lab (explanatory)
[UW, David Baker]

January 9, 2019
https://www.sciencemag.org/news/2019/01/researchers-redesign-cancer-busting-protein-without-side-effects
Abstract:
"UW has licensed Neo-2/15 to a Seattle startup-Neoleukin Therapeutics to bring it to clinical trials"
https://www.genscript.com/antibody-drug-development-news/hope-for-cancer-patients-an-immune-boosting-protein-without-side-effects-created.html (explanatory)
[UW, Rosetta, Neoleukin]